Genetics of hypertrophic cardiomyopathy in eastern Finland: few founder mutations with benign or intermediary phenotypes

In eastern Finland, hypertrophic cardiomyopathy is predominantly caused by a few founder mutations in sarcomeric genes, particularly MYBPC3, which are associated with relatively benign clinical phenotypes.